BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9178397)

  • 21. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure].
    Karkoszka H; Chudek J; Strzelczyk P; Wiecek A; Schmidt-Gayk H; Ritz E; Kokot F
    Pol Merkur Lekarski; 1998 Oct; 5(28):199-202. PubMed ID: 10101442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12 month study.
    Stenova E; Steno B; Killinger Z; Baqi L; Payer J
    Bratisl Lek Listy; 2011; 112(2):71-6. PubMed ID: 21456505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of bone status in patients with central diabetes insipidus.
    Pivonello R; Colao A; Di Somma C; Facciolli G; Klain M; Faggiano A; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2275-80. PubMed ID: 9661594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.
    Evenepoel P; Claes K; Meijers B; Laurent M; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D
    J Bone Miner Res; 2019 Feb; 34(2):262-269. PubMed ID: 30427544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.
    Triantafyllou N; Lambrinoudaki I; Thoda P; Andreadou E; Kararizou E; Alexandrou A; Limouris G; Antoniou A; Tsivgoulis G
    J Neurol Sci; 2012 Feb; 313(1-2):137-41. PubMed ID: 21992813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S; Kajantie E; Dunkel L
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia.
    Terzi R; Dindar S; Terzi H; Demirtaş Ö
    Metab Syndr Relat Disord; 2015 Mar; 13(2):78-83. PubMed ID: 25470355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The level of osteocalcin and bone mass in patients receiving anti-vitamin K agents].
    Houvenagel E; Leloire O; Vanderlinden T; Graux P; Dutoit A; Tison F; Forzy G; Racadot A; Vincent G
    Rev Rhum Mal Osteoartic; 1989 Oct; 56(10):677-9. PubMed ID: 2595229
    [No Abstract]   [Full Text] [Related]  

  • 34. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
    Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density.
    Fitzpatrick LA; Dabrowski CE; Cicconetti G; Gordon DN; Papapoulos S; Bone HG; Bilezikian JP
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2441-9. PubMed ID: 21593114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of oral 1 alpha-hydroxycalciferol treatment on bone mineral density in hemodialysis patients.
    Morita A; Tabata T; Inoue T; Nishizawa Y; Morii H
    Clin Nephrol; 1996 Dec; 46(6):389-93. PubMed ID: 8982555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
    Pearson DA
    Nutr Clin Pract; 2007 Oct; 22(5):517-44. PubMed ID: 17906277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum vitamin K level and bone mineral density in post-menopausal women.
    Kanai T; Takagi T; Masuhiro K; Nakamura M; Iwata M; Saji F
    Int J Gynaecol Obstet; 1997 Jan; 56(1):25-30. PubMed ID: 9049691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oral anticoagulant treatment on markers for calcium and bone metabolism.
    Knapen MH; Hellemons-Boode BS; Langenberg-Ledeboer M; Knottnerus JA; Hamulyák K; Price PA; Vermeer C
    Haemostasis; 2000; 30(6):290-7. PubMed ID: 11356997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.